Pioneering mRNA Therapeutics for the Treatment of Rare Diseases
At ART BioScience we are committed to the development of a new class of therapeutics based on messenger RNA (mRNA) for the treatment of Orphan diseases, primarily Duchenne Muscular Dystrophy
Cure Orphan diseases, primarily Duchenne Muscular Dystrophy
Mr. Oren Ozeri and Mr. Alon Hazan
Company founders, Board Members and current lead investors are fathers to children suffering from DMD and like other parent-driven efforts, are dedicating their resources to the search for an effective therapeutic for DMD.